Cross Country Net Worth
Cross Country Net Worth Breakdown | CCRN |
Cross Country Net Worth Analysis
Cross Country's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Cross Country's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Cross Country's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Cross Country's net worth analysis. One common approach is to calculate Cross Country's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Cross Country's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Cross Country's net worth. This approach calculates the present value of Cross Country's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Cross Country's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Cross Country's net worth. This involves comparing Cross Country's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Cross Country's net worth relative to its peers.
Enterprise Value |
|
To determine if Cross Country is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cross Country's net worth research are outlined below:
| Cross Country generated a negative expected return over the last 90 days | |
| Cross Country has high historical volatility and very poor performance | |
| Cross Country is unlikely to experience financial distress in the next 2 years | |
| Cross Country has a strong financial position based on the latest SEC filings | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Cross Countrys Susan E. Ball Recognized on SIAs Global Power 150 Women in Staffing |
Cross Country Quarterly Good Will |
|
Cross Country uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cross Country Healthcare. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cross Country's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Cross Country's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cross Country is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cross Country Healthcare backward and forwards among themselves. Cross Country's institutional investor refers to the entity that pools money to purchase Cross Country's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Citadel Advisors Llc | 2024-09-30 | 740.3 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 546.9 K | Amvescap Plc. | 2024-06-30 | 517.8 K | Deutsche Bank Ag | 2024-06-30 | 514.6 K | Bank Of America Corp | 2024-06-30 | 458.6 K | Dana Investment Advisors Inc | 2024-09-30 | 404.7 K | Charles Schwab Investment Management Inc | 2024-09-30 | 389.2 K | D. E. Shaw & Co Lp | 2024-09-30 | 388.4 K | Ubs Group Ag | 2024-06-30 | 364.9 K | Blackrock Inc | 2024-06-30 | 5.9 M | Pacer Advisors, Inc. | 2024-06-30 | 4.6 M |
Follow Cross Country's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 340.36 M.Market Cap |
|
Project Cross Country's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.15 | 0.16 | |
| Return On Capital Employed | 0.21 | 0.22 | |
| Return On Assets | 0.11 | 0.11 | |
| Return On Equity | 0.15 | 0.16 |
When accessing Cross Country's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Cross Country's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cross Country's profitability and make more informed investment decisions.
Evaluate Cross Country's management efficiency
Cross Country Healthcare has return on total asset (ROA) of 0.0127 % which means that it generated a profit of $0.0127 on every $100 spent on assets. This is way below average. Cross Country's management efficiency ratios could be used to measure how well Cross Country manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to grow to 0.16. Also, Return On Capital Employed is likely to grow to 0.22. At this time, Cross Country's Return On Assets are very stable compared to the past year. As of the 26th of November 2024, Asset Turnover is likely to grow to 3.12, while Total Assets are likely to drop about 480.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 13.46 | 8.90 | |
| Tangible Book Value Per Share | 8.06 | 8.47 | |
| Enterprise Value Over EBITDA | 6.06 | 6.37 | |
| Price Book Value Ratio | 1.68 | 1.59 | |
| Enterprise Value Multiple | 6.06 | 6.37 | |
| Price Fair Value | 1.68 | 1.59 | |
| Enterprise Value | 374.9 M | 559.5 M |
The strategic initiatives led by Cross Country's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 0.1939 | Revenue 1.4 B | Quarterly Revenue Growth (0.29) | Revenue Per Share 42.699 | Return On Equity (0) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cross Country insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cross Country's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cross Country insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cross Country Corporate Filings
13A | 13th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 6th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 5th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 1st of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Cross Country Earnings per Share Projection vs Actual
Cross Country Corporate Management
| Karen VargaSinka | Director Communications | Profile | |
| Joshua Vogel | Vice Relations | Profile | |
| Colin MS | Chief Officer | Profile | |
| MBA JD | Group Delivery | Profile | |
| Daniel White | Chief Officer | Profile | |
| III CPA | Senior Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.79) | Earnings Share (0.05) | Revenue Per Share 42.699 | Quarterly Revenue Growth (0.29) | Return On Assets 0.0127 |
The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.